BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14

• Press Releases

  Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology

  August 5, 2026

   · 

  7 min read
• Press Releases

  Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference

  August 5, 2026

   · 

  3 min read
• Press Releases

  FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage

  August 5, 2026

   · 

  5 min read
• Press Releases

  Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

  August 5, 2026

   · 

  5 min read
• Press Releases

  Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026

  August 5, 2026

   · 

  2 min read
• 

  Earnings

  Lilly’s $23B Q2 soars over expectations but Foundayo lags Novo’s rival oral GLP-1

  Eli Lilly’s shares rose nearly 5% to $1,170 apiece in premarket trading as the company reported $23 billion in revenue for the second quarter. The company’s market cap is $1.02 trillion as of the end of July.

  August 5, 2026

   · 

  2 min read

   · 

  Annalee Armstrong
• Press Releases

  PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system

  August 5, 2026

   · 

  5 min read
• Press Releases

  CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026

  August 5, 2026

   · 

  5 min read
• Press Releases

  China SXT Pharmaceuticals, Inc. Announces Share Consolidation

  August 5, 2026

   · 

  3 min read
• Press Releases

  RECKITT ANNOUNCES U.S. FDA APPROVAL OF MUCINEX® 12HR COLD & FEVER MULTI-SYMPTOM, THE FIRST OTC INNOVATION IN THE COLD & FLU CATEGORY IN 14 YEARS

  August 5, 2026

   · 

  5 min read